Analyses of publicly available datasets from NSCLC patients further revealed that NINJ1 mRNA expression was significantly elevated in tumor tissues compared to levels in normal tissues (P < 0.001) (Fig. 1c) and was associated with poor overall and relapse-free survival in NSCLC patients (OS: P = 0.0105; RFS: P = 0.0172) (Fig. 1d). This evidence concerns the gene NINJ1 and non-small cell lung carcinoma.